País: Estados Unidos
Língua: inglês
Origem: NLM (National Library of Medicine)
Butalbital (UNII: KHS0AZ4JVK) (Butalbital - UNII:KHS0AZ4JVK), Acetaminophen (UNII: 362O9ITL9D) (Acetaminophen - UNII:362O9ITL9D), Caffeine (UNII: 3G6A5W338E) (Caffeine - UNII:3G6A5W338E), Codeine Phosphate (UNII: GSL05Y1MN6) (Codeine - UNII:Q830PW7520)
Dispensing Solutions, Inc.
Butalbital
Butalbital 50 mg
ORAL
PRESCRIPTION DRUG
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because codeine and butalbital are habit-forming and potentially abusable. This combination product is contraindicated under the following conditions: - Hypersensitivity or intolerance to acetaminophen, caffeine, butalbital, or codeine. - Patients with porphyria. Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules is controlled by the Drug Enforcement Administration and is classified under Schedule III. Codeine can produce drug dependence of the morphine type and, therefore, has the potential for being abused. Psychological dependence, physical dependence, and tolerance may develop upon repeated administration and it sho
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules: Dark blue, opaque cap with a gray, opaque body, and body is imprinted with "B 073" in black ink. Bottles of 100's (NDC 51991-073-01) Store at 20° to 25°C (68° to 77°F) in a tight, light-resistant container. [see USP Controlled Room Temperature].
Abbreviated New Drug Application
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE - BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE CAPSULE DISPENSING SOLUTIONS, INC. ---------- BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE CAPSULES CIII RX ONLY DESCRIPTION Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate is supplied in capsule form for oral administration. Each capsule contains the following active ingredients: Codeine Phosphate, USP ........................................ 30 mg Butalbital, USP ........................................................ 50 mg Caffeine, USP ......................................................... 40 mg Acetaminophen, USP .............................................. 325 mg Codeine phosphate [7,8-didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol phosphate (1:1) (salt) hemihydrate, C H N0 P, anhydrous mw 397.37], is a narcotic analgesic and antitussive. The structural formula of codeine phosphate is: Butalbital (5-allyl-5-isobutylbarbituric acid, C H N 0 , mw 224.26), is a short-to intermediate- acting barbiturate. The structural formula of butalbital is: 18 24 7 11 16 2 3 Caffeine (1,3,7-trimethylxanthine, C H N O , mw 194.19), is a central nervous system stimulant. The structural formula of caffeine is: Acetaminophen (4'-hydroxyacetanilide, C H NO , mw 151.16), is a non-opiate, non-salicylate analgesic and antipyretic. The structural formula of acetaminophen is: _Active Ingredients:_ Codeine Phosphate, USP, Butalbital, USP, Caffeine, USP, and Acetaminophen, USP. _Inactive Ingredients:_ FD&C Blue No. 1, FD&C Red No. 3, FD&C Red No. 40, *FD&C Yellow No.5 (see PRECAUTIONS), Gelatin, Microcrystalline Cellulose, Sodium Lauryl Sulfate, Stearic Acid, Talc, Titanium Dioxide. CLINICAL PHARMACOLOGY Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules is a combination drug product intended as a treatment for tension headache. Butalbital, Acetaminophen, Caffeine and Codeine Phosphate Capsules consists of a fixed combination of butalbital 50 mg, acetaminophen 3 Leia o documento completo